Edesa Biotech, Inc. (EDSA)

Edesa Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 17, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	9	17	14	13	14	98
Market Cap Growth	29.53%	20.29%	8.40%	-6.42%	-85.44%	26.16%
Enterprise Value	-3	14	12	7	1	90
Last Close Price	1.02	2.47	4.45	4.42	6.45	51.66
Forward PE	-	-	-	-	56.67	-
PB Ratio	1.83	1.40	7.29	1.89	1.52	7.49
P/TBV Ratio	3.16	14.32	-	2.74	2.00	9.16
Debt / Equity Ratio	-	-	0.01	0.01	0.00	0.01
Net Debt / Equity Ratio	-0.86	-0.87	-0.51	-0.75	-0.75	-0.59
Net Debt / EBITDA Ratio	1.46	1.39	0.15	0.58	0.39	0.33
Net Debt / FCF Ratio	1.53	1.47	0.21	0.79	0.58	0.57
Quick Ratio	16.51	10.60	0.71	3.29	3.90	7.64
Current Ratio	16.82	10.68	0.91	3.53	4.25	8.29
Return on Equity (ROE)	-96.38%	-99.57%	-136.66%	-101.88%	-156.34%	-120.39%
Return on Assets (ROA)	-55.33%	-57.02%	-69.02%	-56.33%	-87.78%	-116.79%
Return on Capital Employed (ROCE)	-59.90%	-63.50%	-354.10%	-130.50%	-194.70%	-180.40%
Earnings Yield	-91.34%	-41.34%	-42.70%	-62.82%	-123.19%	-13.64%
FCF Yield	-92.23%	-42.12%	-33.84%	-49.78%	-86.24%	-13.98%
Buyback Yield / Dilution	-110.15%	-77.54%	-11.84%	-36.37%	-21.50%	-40.32%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q